6-8 March, 2023
Paris, France

Metabolon will participate in the ESMO Targeted Anticancer Therapies (TAT) Congress 2023 held in Paris, France. This leading congress focuses on promising new anticancer targets and agents with an emphasis on those in early phase clinical development.